Alnylam Pharma Balance Sheet
Alnylam Pharma's total assets for Q4 2025 were $4.97B, an increase of 2.36% from the previous quarter. GB:0HD2 total liabilities were $4.18B for the fiscal quarter, a -9.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.